Ravagalimab
390€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Ravagalimab
Category
Biosimilars
Provider
Abbexa
Reference
abx831470
Tested Applications
ELISA, WB, SDS-PAGE
Description
Ravagalimab is a humanized monoclonal antibody biosimilar expressed in CHO cells, targeting CD40/TNFRSF, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Biosimilars |
| Immunogen Target | Target: CD40/TNFRSF |
| Host | CHO cells |
| Reactivity | Human |
| Assay Data | Concentration: 0.78 mg/ml |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Isotype | IgG1 Kappa |
| Expression | Recombinant |
| Purity | > 95% |
| Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
| Size 1 | 100 µg |
| Size 2 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Buffer | 30 mM Histidine, pH 5.8, containing 10% sucrose, 0.02% Tween. |
| Availability | Shipped within 7-12 working days. |
| Storage | Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles. Shelf Life: 12 months. |
| Dry Ice | No |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. CAS Number: 2050816-56-1 |